Study of 611 for moderate to severe COPD in adults
Part of Lungs & breathing clinical trials.
This trial tests a new medicine called 611 for people with moderate to severe COPD. It aims to see if adding 611 to your current treatments can help prevent flare-ups and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 85 years old.
- You are a current or former smoker with at least a 10 pack-year smoking history (for example, smoking 1 pack a day for 10 years).
- You have been diagnosed with COPD for at least 12 months and have moderate to severe disease.
- You have had at least 2 moderate or 1 severe COPD flare-up in the past year.
- You have been on triple therapy (ICS + LABA + LAMA) for at least 3 months, or double therapy (LABA + LAMA) if you cannot take ICS.
- You do not have asthma, another lung condition, or active infections like hepatitis or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called CM326 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve lung function.
This trial tests a new inhaled drug, HSK39004, to see if it safely improves breathing and quality of life in people with moderate to severe COPD. You may join if you are between 40 and 80, have a COPD diagnosis with certain lung function results, and have at least some shortness of breath with daily activities.
This trial tests a new medicine, Hemay005, in adults with moderate to severe COPD who also have a chronic cough with mucus. It looks at how the drug affects certain markers in the body related to the disease.
This trial tests an experimental tablet called XH-S004 for people with moderate-to-severe COPD. It looks at how safe the drug is, how the body processes it, and if it helps symptoms.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This trial tests a new drug called AZD6793 for people with moderate to very severe COPD. It aims to see if the drug can help improve breathing and reduce flare-ups.
Hear when a new Pulmonary Disease, Chronic Obstructive (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.